New Vaccine Prolongs Life for Glioblastoma Patients
Admin2023-01-20T16:35:21-05:00A major phase III clinical trial has found that DCVax®-L, a dendritic cell brain tumor vaccine, can prolong the lives of patients diagnosed with new or recurrent glioblastomas.